TipRanks
Go Ultimate55% OFF

US Nuclear (UCLE) AI Stock Analysis

UCLE

US Nuclear

(Other OTC:UCLE)

Select Model
Rating:40Underperform
Price Target:$0.02â–²(5.00% Upside)
Action:downgraded
Date:10/17/26

The score of 40 is driven primarily by weak financial performance with persistent losses and negative equity despite improving trends, compounded by weak technical momentum and unattractive valuation from negative P/E.

Positive Factors
Revenue reboundThe 2025 revenue rebound indicates improving demand for the company’s radiation detection and measurement products after weaker performance in 2024. If maintained, stronger sales can improve operating leverage, support investment in the product offering, and provide a foundation for eventual profitability.
Negative Factors
Negative shareholders’ equityA persistently negative equity base indicates accumulated losses and leaves the company with limited balance-sheet flexibility. It reduces the cushion available to absorb setbacks, may constrain capital allocation, and makes continued operating losses more consequential for financing needs and long-term financial stability.

US Nuclear (UCLE) vs. SPDR S&P 500 ETF (SPY)

-100%-80%-60%-40%-20%0%20%UCLE-83.33%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
$1.32M
Dividend Yield
―
Average Volume (3M)
25.82K
Price to Earnings (P/E)
-1.2
Beta (1Y)
-0.20
Revenue Growth
0.25%
EPS Growth
58.57%
Country
US
Employees
8
Sector
Technology
Sector Strength
61
Industry
Hardware, Equipment & Parts

US Nuclear Business Overview & Revenue Model

Company Description

US Nuclear Corp. (UCLE) is a global entity dedicated to the engineering, production, and sale of advanced radiation detection and measurement technologies. The company conducts its operations through two primary divisions: Optron and Overhoff. Its ex...

How the Company Makes Money

U.S. Nuclear generates revenue primarily by selling radiation detection and measurement products (hardware) and related systems/accessories to customers needing radiological monitoring and safety capabilities. To the extent offered, the company may a...

US Nuclear Financial Statement Overview

Summary

Weak financial health with persistent net losses, negative equity, and negative cash flows, though improving gross margins, reduced debt, and lower cash burn provide some positive trajectory amid high risks.

Income Statement

28Negative

Balance Sheet

18Very Negative

Cash Flow

32Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Mar 2023Mar 2022
Income Statement
Total Revenue2.04M2.17M2.19M2.23M2.09M2.14M
Gross Profit896.38K1.09M1.02M924.31K788.07K1.38M
EBITDA-568.04K-1.40M-1.51M-1.78M-1.49M-1.86M
Net Income-865.90K-1.24M-1.74M-3.43M-2.04M-1.88M
Balance Sheet
Total Assets1.64M1.92M2.65M2.86M3.11M2.85M
Cash, Cash Equivalents and Short-Term Investments67.32K134.78K130.84K152.84K126.11K246.32K
Total Debt879.86K916.32K1.78M2.24M1.60M910.27K
Total Liabilities192.90K2.44M3.50M4.84M3.46M2.41M
Stockholders Equity-740.07K-513.69K-856.16K-1.98M-348.30K441.27K
Cash Flow
Free Cash Flow-34.08K-199.34K-509.05K-264.30K-1.32M-447.47K
Operating Cash Flow-34.08K-199.34K-509.05K-263.44K-1.32M-441.03K
Investing Cash Flow00-30.77K-24.55K0-21.45K
Financing Cash Flow232.25K203.28K517.82K314.72K1.20M481.49K

US Nuclear Technical Analysis

Technical Analysis SentimentNegative
Last Price0.02

Price Trends

50DMA0.02Negative
100DMA0.03Negative
200DMA0.05Negative

Market Momentum

MACD-0.00Negative
RSI49.32Neutral
STOCH9.52Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UCLE, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.05, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 49.32 is Neutral, neither overbought nor oversold. The STOCH value of 9.52 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for UCLE.

US Nuclear Risk Analysis

US Nuclear disclosed 33 risk factors in its most recent earnings report. US Nuclear reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

US Nuclear Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

UCLE against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
LGLLGL67Neutral$85.14M-337.50-0.53%―26.35%-130.90%
Sector *61Neutral$37.18B12.37-10.20%1.83%8.50%-7.62%
CPSHCPSH48Neutral$69.60M780.430.15%―25.56%―
MINDMIND46Neutral$36.81M-15.44-5.77%―-28.46%-147.43%
NEONNEON46Neutral$11.09M1.3534.15%―-21.65%―
UCLEUCLE40Underperform$1.29M-1.24186.41%―0.25%58.57%

* Technology Sector Average

Performance Comparison

0%100%200%UCLELGLMINDNEONCPSHIMTEDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
UCLE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
UCLEUS Nuclear Corp0.02-0.10-83.87%
LGLLGL Group6.750.548.70%
MINDMind Technology Inc4.05-7.95-66.25%
NEONNeonode0.66-2.22-77.08%
CPSHCPS Technologies Corp.3.590.102.87%
IMTEIntegrated Media Technology0.45-0.41-47.91%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 17, 2026